{\rtf1\ansi\ansicpg1252\cocoartf2821
\cocoatextscaling0\cocoaplatform0{\fonttbl\f0\fswiss\fcharset0 Helvetica;}
{\colortbl;\red255\green255\blue255;}
{\*\expandedcolortbl;;}
\margl1440\margr1440\vieww11520\viewh8400\viewkind0
\pard\tx720\tx1440\tx2160\tx2880\tx3600\tx4320\tx5040\tx5760\tx6480\tx7200\tx7920\tx8640\pardirnatural\partightenfactor0

\f0\fs24 \cf0 \{\
  "Mucosal Vulvovaginal Melanoma": \{\
    "Workup": [\
      "H&P",\
      "Biopsy, pathologic review",\
      "Imaging",\
      "EUA cystoscopy or proctoscopy as indicated",\
      "Consider somatic mutational testing for vulvar melanoma and mucosal vulvovaginal melanoma as clinically indicated (e.g., BRAF, KIT)",\
      "Full skin assessment"\
    ],\
    "Clinical Stage": \{\
      "Resectable": \{\
        "Primary Treatment": \{\
          "Procedure": "Wide local excision with clear margins (at least 1-cm margin if feasible)",\
          "Consider": "SLNB (sentinel lymph node biopsy)"\
        \},\
        "Adjuvant Treatment": [\
          "Observation",\
          "\'b1 RT (brachytherapy preferred for vaginal lesions)",\
          "\'b1 EBRT",\
          "\'b1 Systemic therapy"\
        ]\
      \},\
      "Unresectable/Residual disease": \{\
        "Primary Treatment": "Systemic therapy \'b1 RT"\
      \}\
    \}\
  \}\
\}\
}